Published in J Am Chem Soc on August 23, 2013
Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complex. J Am Chem Soc (2015) 0.77
Tuning cobalt(III) Schiff base complexes as activated protein inhibitors. Inorg Chem (2015) 0.75
New perspectives of cobalt tris(bipyridine) system: anti-cancer effect and its collateral sensitivity towards multidrug-resistant (MDR) cancers. Oncotarget (2017) 0.75
In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol (2004) 17.47
Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov (2005) 9.47
Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science (2003) 6.92
Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett (2006) 5.63
Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia (2000) 4.42
Nanotechnology applications in cancer. Annu Rev Biomed Eng (2007) 3.88
Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J Am Chem Soc (2004) 3.40
Two-photon absorption standards in the 550-1600 nm excitation wavelength range. Opt Express (2008) 2.29
Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J Am Chem Soc (2007) 1.95
Nanotechnological applications in medicine. Curr Opin Biotechnol (2007) 1.90
New metal complexes as potential therapeutics. Curr Opin Chem Biol (2003) 1.89
Conjugation of luminescent quantum dots with antibodies using an engineered adaptor protein to provide new reagents for fluoroimmunoassays. Anal Chem (2002) 1.79
A potent trans-diimine platinum anticancer complex photoactivated by visible light. Angew Chem Int Ed Engl (2010) 1.74
Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Drug Discov Today (2009) 1.47
Size-dependent valence and conduction band-edge energies of semiconductor nanocrystals. ACS Nano (2011) 1.22
Bioinorganic photochemistry: frontiers and mechanisms. Chem Rev (2005) 1.21
Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate. Proc Natl Acad Sci U S A (2009) 1.15
Chemistry. Metal-based therapeutics. Science (2007) 1.12
Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes. Bioorg Med Chem (1999) 1.11
Redox activation of metal-based prodrugs as a strategy for drug delivery. Adv Drug Deliv Rev (2012) 1.06
Targeted inactivation of Snail family EMT regulatory factors by a Co(III)-Ebox conjugate. PLoS One (2012) 1.05
Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate. Mol Pharm (2012) 1.03
The empirical correlation between size and two-photon absorption cross section of CdSe and CdTe quantum dots. Small (2006) 1.01
Size-dependent extinction coefficients of PbS quantum dots. J Am Chem Soc (2006) 0.94
Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex. J Biol Inorg Chem (2012) 0.90
Cobalt derivatives as promising therapeutic agents. Curr Opin Chem Biol (2012) 0.89
Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics. Inorg Chem (2013) 0.88
Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers. Chem Res Toxicol (2010) 0.88
Poisson-distributed electron-transfer dynamics from single quantum dots to C60 molecules. ACS Nano (2010) 0.87
Rational design of [Co(acacen)L2]+ inhibitors of protein function. Dalton Trans (2013) 0.83
Simultaneous determination of the adsorption constant and the photoinduced electron transfer rate for a CdS quantum dot-viologen complex. J Am Chem Soc (2011) 0.83
Model for adsorption of ligands to colloidal quantum dots with concentration-dependent surface structure. ACS Nano (2011) 0.78
Effective photoreduction of a Pt(IV) complex with quantum dots: a feasible new light-induced method of releasing anticancer Pt(II) drugs. Chem Commun (Camb) (2009) 0.77
Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med (2013) 1.99
Bioresponsive, cell-penetrating, and multimeric MR contrast agents. Acc Chem Res (2009) 1.94
Multimodal MRI contrast agents. J Biol Inorg Chem (2007) 1.86
Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage (2004) 1.86
Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage (2002) 1.82
The synthesis and in vitro testing of a zinc-activated MRI contrast agent. Proc Natl Acad Sci U S A (2007) 1.65
Mechanistic studies of a calcium-dependent MRI contrast agent. Inorg Chem (2002) 1.64
Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents. Nano Lett (2005) 1.59
Gd(III)-nanodiamond conjugates for MRI contrast enhancement. Nano Lett (2010) 1.50
Synthesis of multimeric MR contrast agents for cellular imaging. J Am Chem Soc (2008) 1.49
Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. Angew Chem Int Ed Engl (2009) 1.47
PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness. Prostate (2013) 1.43
A modular system for the synthesis of multiplexed magnetic resonance probes. J Am Chem Soc (2011) 1.40
Lanthanide probes for bioresponsive imaging. Chem Rev (2013) 1.34
Eutectic gallium-indium (EGaIn): a moldable liquid metal for electrical characterization of self-assembled monolayers. Angew Chem Int Ed Engl (2008) 1.32
Magnetic resonance imaging of self-assembled biomaterial scaffolds. Bioconjug Chem (2005) 1.29
Mechanistic investigation of beta-galactosidase-activated MR contrast agents. Inorg Chem (2007) 1.24
The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed (2007) 1.23
Cellular delivery of MRI contrast agents. Chem Biol (2004) 1.20
DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents. J Am Chem Soc (2007) 1.19
Reporter protein-targeted probes for magnetic resonance imaging. J Am Chem Soc (2011) 1.18
A gadolinium chelate for detection of beta-glucuronidase: a self-immolative approach. J Am Chem Soc (2005) 1.16
Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate. Proc Natl Acad Sci U S A (2009) 1.15
Mechanisms of ZnII-activated magnetic resonance imaging agents. Inorg Chem (2008) 1.14
Photoconductance and inverse photoconductance in films of functionalized metal nanoparticles. Nature (2009) 1.14
Targeted inactivation of Snail family EMT regulatory factors by a Co(III)-Ebox conjugate. PLoS One (2012) 1.05
Quantitative imaging of cell-permeable magnetic resonance contrast agents using x-ray fluorescence. Mol Imaging (2006) 1.04
Analytical methods for characterizing magnetic resonance probes. Anal Chem (2012) 1.03
Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate. Mol Pharm (2012) 1.03
Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1. Metallomics (2009) 1.03
Electrochemistry of redox-active self-assembled monolayers. Coord Chem Rev (2010) 1.02
A templating approach for monodisperse self-assembled organic nanostructures. J Am Chem Soc (2008) 1.02
A steroid-conjugated magnetic resonance probe enhances contrast in progesterone receptor expressing organs and tumors in vivo. Mol Pharm (2011) 1.02
Rational design, synthesis, and biological evaluation of progesterone-modified MRI contrast agents. Chem Biol (2007) 1.01
Wire-like charge transport at near constant bridge energy through fluorene oligomers. Proc Natl Acad Sci U S A (2005) 1.01
High-performance nanostructured MR contrast probes. Nanoscale (2010) 0.98
Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release. Angew Chem Int Ed Engl (2010) 0.98
Synthesis and visualization of a membrane-permeable MRI contrast agent. J Biol Inorg Chem (2003) 0.97
Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging. MRS Bull (2009) 0.95
Use of a genetically engineered protein for the design of a multivalent MRI contrast agent. Bioconjug Chem (2007) 0.94
Cell-permeable MR contrast agents with increased intracellular retention. Bioconjug Chem (2008) 0.94
Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence. Biomacromolecules (2010) 0.94
Relaxation of exciton confinement in CdSe quantum dots by modification with a conjugated dithiocarbamate ligand. ACS Nano (2010) 0.94
Preparation of magnetic resonance contrast agents activated by beta-galactosidase. Nat Protoc (2008) 0.93
Mapping the influence of molecular structure on rates of electron transfer using direct measurements of the electron spin-spin exchange interaction. J Am Chem Soc (2003) 0.92
Synthesis and biological evaluation of water-soluble progesterone-conjugated probes for magnetic resonance imaging of hormone related cancers. Bioconjug Chem (2011) 0.92
Charge transport in photofunctional nanoparticles self-assembled from zinc 5,10,15,20-tetrakis(perylenediimide)porphyrin building blocks. J Am Chem Soc (2002) 0.92
Cell labeling via membrane-anchored lipophilic MR contrast agents. Bioconjug Chem (2014) 0.92
Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation. ACS Nano (2014) 0.92
Receptor mediated uptake of a radiolabeled contrast agent sensitive to beta-galactosidase activity. Nucl Med Biol (2003) 0.91
Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex. J Biol Inorg Chem (2012) 0.90
Core-shell and segmented polymer-metal composite nanostructures. Nano Lett (2006) 0.90
A steroid-conjugated contrast agent for magnetic resonance imaging of cell signaling. J Am Chem Soc (2005) 0.90
Cobalt derivatives as promising therapeutic agents. Curr Opin Chem Biol (2012) 0.89
Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics. Inorg Chem (2013) 0.88
Protein polymer MRI contrast agents: Longitudinal analysis of biomaterials in vivo. Magn Reson Med (2011) 0.88
Mechanisms of Gadographene-Mediated Proton Spin Relaxation. J Phys Chem C Nanomater Interfaces (2013) 0.88
Magnetic resonance contrast agents for medical and molecular imaging. Met Ions Biol Syst (2004) 0.87
A novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis. Ann Rheum Dis (2012) 0.87
Fabrication of arrays of metal and metal oxide nanotubes by shadow evaporation. ACS Nano (2008) 0.87
Charge carrier resolved relaxation of the first excitonic state in CdSe quantum dots probed with near-infrared transient absorption spectroscopy. J Phys Chem B (2010) 0.87
A multi-timescale map of radiative and nonradiative decay pathways for excitons in CdSe quantum dots. ACS Nano (2011) 0.86
Modification of embolic-PVA particles with MR contrast agents. Magn Reson Med (2008) 0.86
Chemistry of molecular imaging. Acc Chem Res (2009) 0.86
Probing carbon nanotube-surfactant interactions with two-dimensional DOSY NMR. J Am Chem Soc (2013) 0.86
A molecule to detect and perturb the confinement of charge carriers in quantum dots. Nano Lett (2011) 0.86
Probing the Chemical Stability of Mixed Ferrites: Implications for MR Contrast Agent Design. Chem Mater (2011) 0.85
Molecular imaging of in vivo gene expression. Future Med Chem (2010) 0.84
Highly dispersible, superparamagnetic magnetite nanoflowers for magnetic resonance imaging. Chem Commun (Camb) (2009) 0.84
Synthesis and characterization of a doxorubicin-Gd(III) contrast agent conjugate: a new approach toward prodrug-procontrast complexes. Inorg Chem (2006) 0.84
Spectroscopic elucidation of the inhibitory mechanism of Cys2His2 zinc finger transcription factors by cobalt(III) Schiff base complexes. Chemistry (2013) 0.84
Multimodal imaging enables early detection and characterization of changes in tumor permeability of brain metastases. J Control Release (2013) 0.83
Rational design of [Co(acacen)L2]+ inhibitors of protein function. Dalton Trans (2013) 0.83
Structural optimization of Zn(II)-activated magnetic resonance imaging probes. Inorg Chem (2013) 0.83
Simultaneous determination of the adsorption constant and the photoinduced electron transfer rate for a CdS quantum dot-viologen complex. J Am Chem Soc (2011) 0.83
Advances and innovations in brain arteriovenous malformation surgery. Neurosurgery (2014) 0.82
Kinetic dispersion in redox-active dithiocarbamate monolayers. Langmuir (2010) 0.82
Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation. Proc Natl Acad Sci U S A (2009) 0.82
Synapse-binding subpopulations of Aβ oligomers sensitive to peptide assembly blockers and scFv antibodies. ACS Chem Neurosci (2012) 0.82
The role of ligands in determining the exciton relaxation dynamics in semiconductor quantum dots. Annu Rev Phys Chem (2013) 0.82
Surfactant-controlled polymerization of semiconductor clusters to quantum dots through competing step-growth and living chain-growth mechanisms. J Am Chem Soc (2012) 0.81
Synthesis, Characterization, and in vitro Testing of a Bacteria-Targeted MR Contrast Agent. Eur J Inorg Chem (2012) 0.81
Gd(III)-labeled peptide nanofibers for reporting on biomaterial localization in vivo. ACS Nano (2014) 0.81
A multimeric MR-optical contrast agent for multimodal imaging. Chem Commun (Camb) (2014) 0.81
Theranostic Magnetic Nanostructures (MNS) for Cancer. Cancer Treat Res (2015) 0.81
Synthesis and characterization of new porphyrazine-Gd(III) conjugates as multimodal MR contrast agents. Bioconjug Chem (2010) 0.81
High relaxivity Gd(III)-DNA gold nanostars: investigation of shape effects on proton relaxation. ACS Nano (2015) 0.81
Synthesis and characterization of a porphyrazine-Gd(III) MRI contrast agent and in vivo imaging of a breast cancer xenograft model. Contrast Media Mol Imaging (2014) 0.80
Liver cell labelling with MRI contrast agents. Methods Mol Biol (2009) 0.80
Pillar[5]arene as a co-factor in templating rotaxane formation. J Am Chem Soc (2013) 0.80
The chemical environments of oleate species within samples of oleate-coated PbS quantum dots. Anal Chem (2013) 0.80
Ultrafast modulation of the plasma frequency of vertically aligned indium tin oxide rods. Nano Lett (2014) 0.80
Ferrocene and maleimide-functionalized disulfide scaffolds for self-assembled monolayers on gold. Org Lett (2010) 0.79
Chemical control of the photoluminescence of CdSe quantum dot-organic complexes with a series of para-substituted aniline ligands. J Am Chem Soc (2010) 0.79
Electroactive self-assembled monolayers on gold via bipodal dithiazepane anchoring groups. Langmuir (2008) 0.79